Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Thursday, September 17, 2009

ImmunoGen anti-cancer tech licensed to Amgen

By Julie M. Donnelly

ImmunoGen Inc. will receive up to $35 million, plus royalties, from Thousand Oaks, Calif.-based Amgen Inc. in an exclusive deal to license Immunogen technology. The deal includes $1 million in upfront payments and $34 million in milestone payments, plus royalties on the sales of any resulting products.

Amgen will use the so-called targeted antibody payload technology to develop anti-cancer therapeutics to an undisclosed target found on solid tumors.

Daniel Junius, ImmunoGen president and CEO, commented, “Amgen has an established track record of success in oncology and an expanding presence in antibody-based therapeutics. Amgen’s interest in antibody-drug conjugates is good for the field.”

This license was taken under an agreement established in 2000 between ImmunoGen and Abgenix, Inc., which later was acquired by Amgen. Amgen is responsible for the development, manufacturing, and marketing of any products resulting from this license.

 

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Comments

Please Login/Register to post comments.

No comments have been added or approved.

On the MHT blog now

Flagsuit wins another NASA Astronaut Glove Challenge

Southwest Harbor, Maine's Peter Homer won $450,000 in NASA's Astronaut Glove Challenge yesterday. This is Homer's second time winning the contest. Homer's first win in 2007 launched his startup, Flagsuit. Flagsuit is developing pressure suits using the same technology as Homer's prizewinning gloves -- for use as a wearable substitute for hyperbaric chambers used to treat conditions such as ...

Read More

Most Popular Stories
EmailedViewed
Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
FinanceFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of, registration on, this site constitutes acceptance of our User Agreement. Please read our Privacy Policy (updated) A publishing partner with Portfolio